Vasculitides are a heterogeneous group of inflammatory diseases affecting blood vessels, ranging from ANCA-associated vasculitis affecting small vessels to large-vessel disease including giant cell arteritis. Rituximab has established itself alongside cyclophosphamide for ANCA-associated vasculitis induction and maintenance. Tocilizumab is now guideline-recommended for glucocorticoid tapering in giant cell arteritis.
EGPA: Early Recognition & Targeted Intervention Improve Outcomes
Eosinophilic granulomatosis with polyangiitis (EGPA) presents diagnostic challenges; timely intervention is critical for improved patient outcomes.
VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026
EULAR 2026 discussions highlight the need for integrated, multidisciplinary approaches to VEXAS syndrome, focusing on early diagnosis and targeted management.
ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention
New strategies in ANCA-associated vasculitis (GPA/MPA) focus on achieving sustained remission and preventing relapse with targeted therapies.